A multiple testing procedure for multi-dimensional pairwise comparisons with application to gene expression studies

BMC Bioinformatics

Volumn 17, Issue 1, 2016, Pages

  Grandhi, Anjana ^a   Guo, Wenge ^b   Peddada, Shyamal D ^c  

^a MERCK RESEARCH LABORATORIES   (United States)

^b NEW JERSEY INSTITUTE OF TECHNOLOGY   (United States)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

BH procedure; Differential gene expression; MdFDR; Multiple testing; Tumor size

Indexed keywords

GENES; STATISTICAL TESTS; TUMORS;

BH PROCEDURE; DIFFERENTIAL GENE EXPRESSIONS; MDFDR; MULTIPLE TESTING; TUMOR SIZE;

GENE EXPRESSION;

FEMALE; GENE EXPRESSION; GENETICS; HUMAN; LEIOMYOMA; UTERUS CANCER;

FEMALE; GENE EXPRESSION; HUMANS; LEIOMYOMA; UTERINE NEOPLASMS;

EID: 84959177668     PISSN: None     EISSN: 14712105     Source Type: Journal    
DOI: 10.1186/s12859-016-0937-5     Document Type: Article

References (36)

1. Hoenerhoff MJ, Pandiri AR, Lahousse SA, Hong HH, Ton TV, Masinde T, et al.Global gene profiling of spontaneous hepatocellular carcinoma in b6c3f1 mice: Similarities in the molecular landscape with human liver cancer. J Toxicol Pathol. 2011; 39:678-99.
2. Hoenerhoff MJ, Pandiri AR, Snyder SA, Hong HH, Ton TV, Peddada SD, et al.Hepatocellular carcinomas in b6c3f1 mice treated with ginkgo biloba extract for two years differ from spontaneous liver tumors in cancer gene mutations and genomic pathways. J Toxicol Pathol. 2012; 41:826-41.
3. Pandiri AR, Sills RC, Hoenerhoff MJ, Peddada SD, Ton TV, Hong HH, et al.Aloe vera non-decolorized whole leaf extract-induced large intestinal tumors in f344 rats share similar molecular pathways with human sporadic colorectal tumors. J Toxicol Pathol. 2011; 39:1065-74.
4. Pandiri AR, Sills RC, Ziglioli V, Ton TV, Hong HH, Lahousse SA, et al.Differential transcriptomic analysis of spontaneous lung tumors 1 in b6c3f1 mice: 2 comparison to human non-small cell lung cancer. J Toxicol Pathol. 2012; 40:1141-59.
5. Diaz LK, Cristofanilli M, Zhou X, Welch KL, Smith TL, Yang Y, et al. β4 integrin subunit gene expression correlates with tumor size and nuclear grade in early breast cancer. Mod Pathol. 2005; 18:1165-75.
6. Gieseg M, Man M, Gorski N, Madore S, Kaldjian E, Leopold W. The influence of tumor size and environment on gene expression in commonly used human tumor lines. BMC Cancer. 2004; 4:35.
7. Hu J, Locasale JW, Bielas JH, O'Sullivan J, Sheahan K, Cantley LC, et al.Heterogeneity of tumor-induced gene expression changes in the human metabolic network. Nat Biotechnol. 2013; 31:522-9.
8. Minn AJ, Gupta GP, Padua D, Bos P, Nguyen DX, Nuyten D, et al.Lung metastasis genes couple breast tumor size and metastatic spread. Proc Natl Acad Sci. 2007; 104:6740-5.
9. Riis MLH, Zhao X, Kaveh F, Vollan HS, Nesbakken A, Solvang HK, et al.Gene expression profile analysis of t1 and t2 breast cancer reveals different activation pathways. ISRN Oncol. 2013; 2013:12.
10. Dunne A, O'Neill LAJ. The interleukin-1 receptor/toll-like receptor superfamily: Signal transduction during inflammation and host defense. Science's STKE. 2003; 2003:3.
11. Sun KLW, Correia JP, Kennedy TE. Netrins: Versatile extracellular cues with diverse functions. Development. 2011; 138:2153-69.
12. Ciarmela P, Islam MS, Reis FM, Gray PC, Bloise E, Petraglia F, et al.Growth factors and myometrium: biological effects in uterine fibroid and possible clinical implications. Hum Reprod Update. 2011; 17:772-90.
13. Shaffer JP. Control of directional errors with stagewise multiple test procedures. Ann Stat. 1980; 8:1342-7.
14. Finner H. Stepwise multiple test procedures and control of directional errors. Ann Stat. 1999; 27:274-89.
15. Liu W. Control of directional errors with step-up multiple tests. Stat Probab Lett. 1997; 31:239-42.
16. Sarkar SK, Sen PK, Finner H. In: (Benjamini Y, Bretz F, Sarkar S, editors.)On two results in multiple testing, vol. 47: Institute of Mathematical Statistics; 2004, pp. 89-99.
17. Guo W, Sarkar SK, Peddada SD. Controlling false discoveries in multidimensional directional decisions, with applications to gene expression data on ordered categories. Biometrics. 2010; 66:485-92.
18. Benjamini Y, Yekutieli D. False discovery rate-adjusted multiple confidence intervals for selected parameters. J Am Stat Assoc. 2005; 100:71-81.
19. Dunnett CW. A multiple comparison procedure for comparing several treatments with a control. J Am Stat Assoc. 1955; 50:1096-121.
20. Dunnett CW, Tamhane AC. Step-down multiple tests for comparing treatments with a control in unbalanced one-way layouts. Stat Med. 1991; 10:939-47.
21. Dunnett CW, Tamhane AC. A step-up multiple test procedure. J Am Stat Assoc. 1992; 87:162-70.
22. Peddada SD, Laughlin SK, Miner K, Guyon JP, Haneke K, Vahdat HL, et al.Growth of uterine leiomyomata among premenopausal black and white women. Proc Natl Acad Sci. 2008; 105:19887-92.
23. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B. 1995; 57:289-300.
24. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat. 1979; 6:65-70.
25. Hochberg Y. A sharper bonferroni procedure for multiple tests of significance. Biometrika. 1988; 75:800-2.
26. Dudoit S, Shaffer JP, Boldrick JC. Multiple hypothesis testing in microarray experiments. Stat Sci. 2003; 18:71-103.
27. Efron B, Tibshirani R, Storey JD, Tusher V. Empirical bayes analysis of a microarray experiment. J Am Stat Assoc. 2001; 96:1151-60.
28. Efron B, Tibshirnai R. Empirical bayes methods and false discovery rates for microarrays. Genet Epidemiol. 2002; 23:70-86.
29. Davis BJ, Risinger JI, Chandramouli GVR, Bushel PR, Baird DD, Peddada SD. Gene expression in uterine leiomyoma from tumors likely to be growing (from black women over 35) and tumors likely to be non-growing (from white women over 35). PLoS ONE. 2013; 8:63909.
30. Lejmi E, Leconte L, Pédron-Mazoyer S, Ropert S, Raoul W, Lavalette S, et al.Netrin-4 inhibits angiogenesis via binding to neogenin and recruitment of unc5b. Proc Natl Acad Sci. 2008; 105:12491-6.
31. Epting D, Wendik B, Bennewitz K, Dietz CT, Driever W, Kroll J. The rac1 regulator elmo1 controls vascular morphogenesis in zebrafish. Circ Res. 2010; 107:45-55.
32. Jabbour HN, Sales KJ, Smith OP, Battersby S, Boddy SC. Prostaglandin receptors are mediators of vascular function in endometrial pathologies. Mol Cell Endocrinol. 2006; 252:191-200.
33. Wolanska M, Bańkowska-Guszczyn E, Jaworski S. Fibroblast growth factor gene expression in uterine leiomyomas. Ginekol Pol. 2008; 79:555-9.
34. Talaulikar VS, Manyonda I. Progesterone and progesterone receptor modulators in the management of symptomatic uterine fibroids. Eur J Obstet Gynecol Reprod Biol. 2012; 165:135-40.
35. Houston KD, Copland JA, Broaddus RR, Gottardis MM, Fischer SM, Walker CL. Inhibition of proliferation and estrogen receptor signaling by peroxisome proliferator-activated receptor γ ligands in uterine leiomyoma. Cancer Res. 2003; 63:1221-7.
36. Nam DH, Ramachandran S, Song DK, Kwon KY, Jeon DS, Shin SJ, et al.Growth inhibition and apoptosis induced in human leiomyoma cells by treatment with the ppar γ ligand ciglitizone. Mol Hum Reprod. 2007; 13:829-36.